123 related articles for article (PubMed ID: 11271189)
1. Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group.
Undre N; Möller A
Transpl Int; 1994; 7 Suppl 1():S15-21. PubMed ID: 11271189
[TBL] [Abstract][Full Text] [Related]
2. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
3. Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study.
Ericzon B; Groth C; Bismuth H; Calne R; McMaster P; Neuhaus P; Otto G; Pichlmayr R; Williams R
Transpl Int; 1994; 7 Suppl 1():S11-4. PubMed ID: 11271178
[TBL] [Abstract][Full Text] [Related]
4. Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group.
Transpl Int; 1994; 7 Suppl 1():S247-51. PubMed ID: 11271216
[TBL] [Abstract][Full Text] [Related]
5. Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation.
Winkler M; Pichlmayr R; Neuhaus P; McMaster P; Calne R; Otto G; Williams R; Bismuth H; Groth C
Transpl Int; 1994; 7 Suppl 1():S58-63. PubMed ID: 11271312
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.
Venkataramanan R; Shaw LM; Sarkozi L; Mullins R; Pirsch J; MacFarlane G; Scheller D; Ersfeld D; Frick M; Fitzsimmons WE; Virji M; Jain A; Brayman KL; Shaked A
J Clin Pharmacol; 2001 May; 41(5):542-51. PubMed ID: 11361051
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoepidemiology of tacrolimus in pediatric liver transplantation.
Riva N; Schaiquevich P; Cáceres Guido P; Halac E; Dip M; Imventarza O
Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28574195
[TBL] [Abstract][Full Text] [Related]
10. Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients.
Devlin J; Williams R; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Bismuth H; Groth C
Transpl Int; 1994; 7 Suppl 1():S22-6. PubMed ID: 11271207
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of FK 506 in living related liver transplantation.
Uemoto S; Tanaka K; Tokunaga Y; Nishizawa T; Sawada H; Katoh H; Yamamoto E; Yamaoka Y; Ozawa K
Transpl Int; 1994; 7 Suppl 1():S81-4. PubMed ID: 11271341
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Richards TM; Crotty PH; Beaver SJ; Steers JL; Wiesner RH
Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
[TBL] [Abstract][Full Text] [Related]
14. Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients.
Rudant E; Bezie Y; Bonhomme-Faivre L; Manuel N; Rucay P; Fredj G; Bismuth H
J Clin Pharm Ther; 1997 Apr; 22(2):135-40. PubMed ID: 9373812
[TBL] [Abstract][Full Text] [Related]
15. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
[TBL] [Abstract][Full Text] [Related]
16. Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation.
Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Bismuth H; Groth C
Transpl Int; 1994; 7 Suppl 1():S27-31. PubMed ID: 11271222
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls in monitoring tacrolimus (FK 506).
Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
[TBL] [Abstract][Full Text] [Related]
18. Patient and graft survival in the European Multicentre Liver Study--FK 506 vs cyclosporin A.
McMaster P
Transpl Int; 1994; 7 Suppl 1():S32-6. PubMed ID: 11271239
[TBL] [Abstract][Full Text] [Related]
19. Elimination of FK-506 by continuous hemodiafiltration in a liver transplant patient.
Tsubo T; Iwakawa T; Muraoka M; Ishihara H; Matsuki A
ASAIO J; 1997; 43(4):363-4. PubMed ID: 9242954
[TBL] [Abstract][Full Text] [Related]
20. Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study.
Solari S; Cancino A; Wolff R; Norero B; Vargas JI; Barrera F; Guerra JF; Martínez J; Jarufe N; Soza A; Arrese M; Benitez C
Aliment Pharmacol Ther; 2017 May; 45(9):1225-1231. PubMed ID: 28261844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
